ABSTRACT - 600933 The disclosure relates to the use of a dietary composition comprising a fiber composition comprising from about 48% to about 90% (w/w) glucomannan, from about 5% to about 20% (w/w) xanthan gum, and from about 5% to about 30% (w/w) alginate in the 5 manufacture of a medicament for reducing the glycemic volatility in a subject in need thereof； wherein the medicament is adapted for administration to the subject in an amount from 5.0g to 15.0g per day, and wherein the medicament is adapted for administration to the subject for at least 4 week, and wherein the fiber composition comprises granules in the size range of from about 40 mesh to about 60 mesh.
